The Resource Cancer vaccines : 6th international symposium, edited by Ralph Steinman, Jacques Banchereau, Olivera J. Finn, (electronic resource)

Cancer vaccines : 6th international symposium, edited by Ralph Steinman, Jacques Banchereau, Olivera J. Finn, (electronic resource)

Label
Cancer vaccines : 6th international symposium
Title
Cancer vaccines
Title remainder
6th international symposium
Statement of responsibility
edited by Ralph Steinman, Jacques Banchereau, Olivera J. Finn
Title variation
Cancer vaccines
Title variation remainder
sixth international symposium
Creator
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
MMU
Illustrations
illustrations
Index
no index present
Literary form
non fiction
http://bibfra.me/vocab/lite/meetingDate
2008
http://bibfra.me/vocab/lite/meetingName
International Cancer Vaccine Symposium
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Steinman, Ralph
  • Banchereau, Jacques
  • Finn, Olivera J
Series statement
Annals of the New York Academy of Sciences,
Series volume
v. 1174
http://library.link/vocab/subjectName
  • Cancer vaccines
  • Cancer Vaccines
Label
Cancer vaccines : 6th international symposium, edited by Ralph Steinman, Jacques Banchereau, Olivera J. Finn, (electronic resource)
Instantiates
Publication
Note
  • "September 2009."
  • Title from resource title screen (WileyInterScience, viewed Sept. 15, 2009)
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Some scientific and organizational challenges in cancer immunology -- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells -- Brain tumor immunotherapy with type-1 polarizing strategies -- Harnessing human dendritic cell subsets to design novel vaccines -- Dendritic cell-based vaccines for pancreatic cancer and melanoma -- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers -- Witch hunt against tumor cells enhanced by dendritic cells -- Harnessing CD1D-restricted t cells toward antitumor immunity in humans -- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice -- Targets of protective tumor immunity -- Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer -- Harnessing dendritic cells to generate cancer vaccines -- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells -- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model -- Hematopoietic stem and progenitor cells and the inflammatory response
Control code
436727586
Extent
1 electronic resource (121 pages)
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote
System control number
(OCoLC)436727586
Label
Cancer vaccines : 6th international symposium, edited by Ralph Steinman, Jacques Banchereau, Olivera J. Finn, (electronic resource)
Publication
Note
  • "September 2009."
  • Title from resource title screen (WileyInterScience, viewed Sept. 15, 2009)
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Some scientific and organizational challenges in cancer immunology -- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells -- Brain tumor immunotherapy with type-1 polarizing strategies -- Harnessing human dendritic cell subsets to design novel vaccines -- Dendritic cell-based vaccines for pancreatic cancer and melanoma -- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers -- Witch hunt against tumor cells enhanced by dendritic cells -- Harnessing CD1D-restricted t cells toward antitumor immunity in humans -- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice -- Targets of protective tumor immunity -- Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer -- Harnessing dendritic cells to generate cancer vaccines -- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells -- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model -- Hematopoietic stem and progenitor cells and the inflammatory response
Control code
436727586
Extent
1 electronic resource (121 pages)
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote
System control number
(OCoLC)436727586

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...